key: cord-0959943-23qc4xv2 authors: Hamilton, M.C.K.; Lyen, S.; Manghat, N.E. title: Re: Controversy in coronaViral Imaging and Diagnostics (COVID). A reply date: 2020-08-27 journal: Clin Radiol DOI: 10.1016/j.crad.2020.08.001 sha: c0e401972c236430c341cddb1df1d4652ab4f76d doc_id: 959943 cord_uid: 23qc4xv2 nan SirdWe thank our Moscow colleagues for their kind words regarding our scientific letter 1 and for sharing their experience. 2 They highlight their practical experience of using computed tomography (CT) to triage patients with suspected COVID-19 in the context of a high prevalence of the disease and insufficient numbers of reverse transcription polymerase chain reaction (RT-PCR) tests or associated delays. We note that they describe a very different cohort of patients from the asymptomatic patients we were considering for screening. They do provide compelling data to suggest that CT is indeed as "a valuable tool for indicating the need for hospitalisation of patients with suspected COVID-19, especially in densely populated areas."; however, we are not able in this cohort to calculate the true accuracy of CT to diagnose COVID-19 as we have no idea of the true and false positive and negative rates, so accuracy cannot be determined. From the data 3 we quoted, if a 50% prevalence of the disease is assumed in those tested, this would provide a post-test positive predictive value (PPV) of 56%, negative predictive value (NPV) 88%, overall test accuracy of 61%; with a 75% prevalence of the disease in those tested would give a post-test PPV of 80%, NPV 71%, accuracy of 79%, and if a 90% prevalence of the disease is assumed, the post-test PPV is 92%, NPV 45%, and the accuracy is 89%. None of these statistics provide compelling evidence for the use of CT to diagnose COVID-19 per se. Whether it helps triage for hospitalisation is, of course, another matter. We would urge our colleagues to "close the loop" on their potentially powerful dataset by looking at their correlative results of RT-PCR versus the CT findings so that PPV, NPV, and accuracy can be determined. It is our view that too many radiological investigations are recommended based on sensitivity/specificity data, but without considering prevalence in the cohort being tested. We would be interested to see if CT added any further diagnostic value to the usual clinical and vital signs of "illness"; for example, if all those admitted to hospital were significantly hypoxic, one presumes that CT did not add very much to the "triage for hospitalisation", other than additional (perhaps unnecessary) workload and cost, and perhaps compromising other areas of healthcare. The Controversy in coronaViral Imaging and Diagnostics persists, and by extension, also in other areas of imaging. Re: Predictors for 30-day mortality and complications following radiologically inserted gastrostomies: a single centre, large cohort review SirdWe read with interest the paper by Delf and coworkers in the Journal in which they identified predictors of mortality and morbidity following radiologically inserted gastrostomies (RIGs). 1 Firstly, we would like to congratulate the authors on their well-designed and clinically important study. In Table 5 of the paper, the authors display the results from their multivariate analysis comparing clinical variables with potential complications. In total, 196 comparisons are made identifying associations between 28 variables and seven complications. The authors state that at a probability value of <0.05, they would consider an association to be significant; however, they have not stated whether they have made any corrections for the multiple comparisons made. 2 Without corrections, one might predict of the 196 comparisons made approximately 10 would return significant p-values by chance alone. In addition, in the situation where there are no true associations between complications and the variables listed the probability of having at least one type I error from these comparisons is 0.99996. Although conservative, applying the Bonferroni method for the comparisons made would make the new p-value threshold 0.00025. If this was applied, only seven of the 19 previously identified statistically significant associations would remain. Furthermore if corrections have not been made, then it may help to explain some of the associations that appeared to reach statistical significance in the table without a clear clinical explanation, for example, why certain indications for RIG insertion or certain comorbidities were associated with RIG tube fracture. Controversy in coronaViral imaging and diagnostics (COVID) Reported cases and deaths by country, territory, or conveyance The population of the Russian Federation by municipal districts as of Current population estimates: NYC Error in radiology chest CT scans with COVID-19 related findings dataset Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing Controversy in coronaViral imaging and diagnostics (COVID) Re: controversy in coronaViral imaging and diagnostics (COVID) Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 Cases The authors declare no conflict of interest. The authors declare no conflict of interest. The authors declare no conflict of interest. Re: The accuracy of bone mineral density measurement using dual-energy spectral CT and quantitative CT: a comparative phantom study SireI was interested in reading the paper by Li and colleagues that was published in the Journal. 1 The aim of the authors was to compare bone mineral density (BMD) measurement accuracy using dual-energy spectral computed tomography (CT) and quantitative CT (QCT) using an anthropomorphic European spine phantom (ESP). An ESP containing three hydroxyapatite inserts with densities of 50, 100, and 200 mg/cm 3 was scanned 10 times each using spectral CT and QCT protocols. Their BMD values were measured using hydroxyapatite-based spectral CT material decomposition images and QCT images and compared with the true values in ESP. They reported that both protocols